1. Rönkkö, Julius, Molchanova, Svetlana, Revah-Politi, Anya, Tyynismaa, Henna, Ylikallio, Emil. 2020. Dominant mutations in ITPR3 cause Charcot-Marie-Tooth disease. In Annals of clinical and translational neurology, 7, 1962-1972. doi:10.1002/acn3.51190. https://pubmed.ncbi.nlm.nih.gov/32949214/
2. Molitor, Anne, Lederle, Alexandre, Radosavljevic, Mirjana, Bertoli-Avella, Aida, Bahram, Seiamak. 2024. A pleiotropic recurrent dominant ITPR3 variant causes a complex multisystemic disease. In Science advances, 10, eado5545. doi:10.1126/sciadv.ado5545. https://pubmed.ncbi.nlm.nih.gov/39270020/
3. Xue, Yibo, Morris, Jordan L, Yang, Kangning, Prudent, Julien, Huang, Sidong. 2021. SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria. In Nature communications, 12, 5404. doi:10.1038/s41467-021-25260-9. https://pubmed.ncbi.nlm.nih.gov/34518526/
4. Moy, Ryan H, Nguyen, Alexander, Loo, Jia Min, Tavazoie, Saeed, Tavazoie, Sohail F. 2022. Functional genetic screen identifies ITPR3/calcium/RELB axis as a driver of colorectal cancer metastatic liver colonization. In Developmental cell, 57, 1146-1159.e7. doi:10.1016/j.devcel.2022.04.010. https://pubmed.ncbi.nlm.nih.gov/35487218/
5. Blanco, Elena, Camps, Carme, Bahal, Sameer, Dhalla, Fatima, Kreins, Alexandra Y. 2024. Dominant negative variants in ITPR3 impair T cell Ca2+ dynamics causing combined immunodeficiency. In The Journal of experimental medicine, 222, . doi:10.1084/jem.20220979. https://pubmed.ncbi.nlm.nih.gov/39560673/
6. Zheng, Wangyang, Bai, Xue, Zhou, Yongxu, Xu, Yi, Cui, Yunfu. 2022. Transcriptional ITPR3 as potential targets and biomarkers for human pancreatic cancer. In Aging, 14, 4425-4444. doi:10.18632/aging.204080. https://pubmed.ncbi.nlm.nih.gov/35580861/
智鼠故事 
